This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Institute of Transfusion Medicine, Academy of Military Medical Sciences, People's Libration Army of China. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: **Innovations by Shuyong Wang: Pioneering Stem Cell Research**
Introduction
Shuyong Wang is a notable inventor based in Beijing, China, recognized for his significant contributions to stem cell research. With a focus on reprogramming digestive tract-derived epithelial cells, Wang's innovative approach has the potential to revolutionize regenerative medicine and therapeutic applications.
Latest Patents
Wang holds a patent for a groundbreaking development titled "Small molecule compound combination for reprogramming digestive tract derived epithelial cells to endodermal stem/progenitor cells, reprogramming method and application." This patent elucidates a methodology that employs human gastric epithelial cells (hGECs) as initiators, utilizing a specific compound combination including FBP, Bay K 8644, and others. These advancements facilitate the reprogramming of cells into endodermal stem/progenitor cells, which can be differentiated into liver cells, pancreatic beta cells, and intestinal cells.
Career Highlights
Shuyong Wang is affiliated with the Institute of Transfusion Medicine at the Academy of Military Medical Sciences, part of the People's Liberation Army of China. His role in this prestigious institution highlights his dedication to advancing medical science through innovative research and development.
Collaborations
Wang has collaborated with esteemed colleagues, including Yunfang Wang and Wencheng Zhang. These partnerships exemplify the collaborative spirit often found in cutting-edge research environments, where diverse expertise contributes to shared goals in scientific innovation.
Conclusion
Shuyong Wang's contributions to the field of stem cell research signify important strides in medical science. His patent on the reprogramming of digestive tract-derived epithelial cells showcases his innovative thinking and potential impact on future therapies. With a strong foundation in research and collaboration, Wang continues to pave the way for advancements that may benefit countless individuals in need of regenerative treatments.